Dendrimer-Based Nanoplatforms for Cancer Diagnosis and Therapy: from Liquid Biopsy to Targeted Protein Degradation
Dendrimer-based systems have shown considerable potential to remodel the tumor microenvironment, induce immunogenic cell death, enhance immune activation, and facilitate combination therapies, offering promising opportunities to improve cancer diagnosis, treatment, and patient outcomes.